Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: Ammonia, long regarded as a metabolic waste product, has recently been recognized as a p...
The gut microbiome functions as a key regulator of tumorigenesis and progression, thereby modulating...
INTRODUCTION: Population cancer screening detects the presence of early-stage disease rather than as...
Hypoxia is a hallmark of oral squamous cell carcinoma (OSCC) and plays a critical role in driving tu...
Artificial intelligence (AI) is reshaping cancer research and clinical oncology by enabling large-sc...
Glioma is a primary tumor derived from central nervous system glial cells. RNA binding motif protein...
Vasoactive intestinal peptide (VIP) plays a multifaceted role in cancer biology, yet its prognostic ...
The construction of 3D in vitro tumor models centered on bioprinting technology represents one of th...
PURPOSE: The purpose of this study was to use transmission electron miscroscopy images to develop a ...
This collection of reviews and research articles highlights the diagnostic and therapeutic potential...
BACKGROUND: Accurate preoperative differentiation between benign and malignant parotid gland tumors ...
BACKGROUND: Warfarin dosing in cancer patients is challenging due to altered pathophysiology and var...
Sleep medicine has rapidly adopted artificial intelligence, but most applications still prioritize a...
Background Acute myeloid leukemia (AML) remains a lethal hematologic malignancy with high heterogene...
OBJECTIVE: Artificial intelligence (AI) is transforming medical imaging and radiation oncology, yet ...
Cancer therapeutics account for a significant proportion of new drug development, reflecting advance...
PURPOSE: Patients with prostate cancer (PC) face elevated cardiovascular (CV) risk. Conventional CV ...
Glioblastoma exhibits profound intratumoral heterogeneity and rapid adaptation under stress, complic...
Brain tumors remain a major public health challenge because of their high mortality rate and the nee...
BACKGROUND AND OBJECTIVE: Neoadjuvant immune-checkpoint inhibitors (ICIs) in muscle-invasive bladder...
Non-muscle-invasive bladder cancer (NMIBC) has high rates of recurrence and progression, yet its mol...